Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Biopharmaceutical CMO Market?
The market size for biopharmaceutical CMO has seen swift expansion in the past years. The projection indicates a rise from $24.81 billion in size in 2024 up to $28.02 billion by 2025, with a compound annual growth rate (CAGR) of 12.9%. The surge during the historic phase can be linked to rising demands for biopharmaceuticals, globalization, increase in healthcare spending, regulatory backing, and a boost in research funding.
Explosive expansion will be observed in the biopharmaceutical cmo market size in the coming years, projected to reach $47.79 billion by 2029, based on a compound annual growth rate (CAGR) of 14.3%. The growth projected over this period can be ascribed to the increased use of telehealth and remote trials, worldwide health initiatives and an increase in disposable income. Dominance in advanced therapies, digitalization, industry 4.0 revolution, continuous manufacturing and adoption of sustainable and green practices are forecasted to be the key trends over this period.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp
Which Industry Forces Are Driving The Biopharmaceutical CMO Market Forward?
The growth of the biopharmaceutical CMO market is anticipated to be fuelled by a rise in the elderly population. Individuals who are over 60 years old are more prone to health issues such as heart attacks, strokes, coronary heart diseases, and heart failure compared to their younger counterparts. Factors such as advancements in healthcare, decreasing birth rates, and the ageing baby boomer generation contribute to the rising geriatric population. This, in turn, creates a demand for biopharmaceutical therapies aimed at treating age-related diseases, including cardiovascular disorders, and it’s here that biopharmaceutical CMOs step in by offering specialised manufacturing abilities for intricate biologics and personalised medications designed to cater to these requirements. Taking an example from the Population Reference Bureau, a non-profit organization based in the US, the number of Americans aged 65 and above is projected to increase from 58 million in 2022 to 82 million by 2050. Hence, the biopharmaceutical CMO market’s growth is being propelled by the surge in the older population.
How Is The Biopharmaceutical CMO Market Organized By Different Segments?
The biopharmaceutical cmomarket covered in this report is segmented –
1) By Product: Biologics; Biosimilars
2) By Source: Mammalian; Non-Mammalian
3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging
Subsegments:
1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Cell and Gene Therapies
2) By Biosimilars: Biosimilar Monoclonal Antibodies; Biosimilar Recombinant Proteins; Biosimilar Insulins; Biosimilar Growth Hormones
What Current And Upcoming Trends Are Shaping The Biopharmaceutical CMO Market?
Embracing technological progression is becoming a key trend in the biopharmaceutical CMO market. Notably, significant players in this niche are pushing the limits of innovation by utilizing internet of things (IoT) in their technology advancement and research endeavors. The IoT essentially utilizes networked sensors and actuators to control and monitor the environment, the objects within it, and its human interactors. These tools, integrated with manufacturing equipment and networked computer systems, can generate copious amounts of data. This data, when examined, unveils insights and opportunities for enhancing production efficiency, automating control and monitoring operations, along with facilitating adaptable manufacturing systems. For example, in February 2022, M2Cloud, based in Korea, in collaboration with Thales, a French company known for IoT communication modules, introduced an IoT-driven LTE monitoring system for overseeing biopharmaceutical processes. This practical solution provides a real-time tracking of freezers, refrigerated warehouses and even the delivery boxes in transit. All this can be done remotely by checking temperature and positional information in real time, just by switching on the power. Equipped with such cutting-edge technologies specifically designed for biopharmaceutical operations, the safety of pharmaceutical products increases significantly.
Who Are The Primary Market Leaders In The Biopharmaceutical CMO Market?
Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report
How Do Regional Dynamics Influence The Biopharmaceutical CMO Market Performance?
North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp
Browse Through More Reports Similar to the Global Biopharmaceutical CMO Market 2025, By The Business Research Company
Animal And Pet Food Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/animal-and-pet-food-global-market-report
Greenhouse Nursery And Flowers Global Market Report 2025
Crop Production Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crop-production-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model